Anti‐VEGF vs steroids
Adverse outcomes at any time point · people with BRVO
Anti‐VEGF probably leads to lower adverse outcomes at any time point compared with steroid (moderate certainty).
1 finding from 1 review
- Anti‐vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion 2020 · Cochrane Headline outcomes onlyRR 0.12 [0.04, 0.32]3 studies · 551 participantsModerate